Perimenopause was linked to higher PsA disease activity and greater tender/swollen joint counts when compared with the pre- ...

Treatment with TNF-α inhibitors may be safer than IL-6 inhibitors in terms of cardiovascular outcomes when managing patients ...

(HealthDay News) — Having optimal cardiovascular health (CVH) is associated with a reduced risk for mild cognitive impairment (MCI) among people with type 2 diabetes, according to a study presented at ...

Patients with AAV and kidney involvement who take SGLT-2 inhibitors may have a reduced risk for ESRD and kidney transplant ...

Researchers assessed the effect of physical activity levels on the progression of Alzheimer disease pathology among older adult without cognitive impairment.

The trial's first transplantation has already taken place at NYU Langone Health, with as many as 50 patients potentially joining the study.

(HealthDay News) — For adults with type 2 diabetes, low-dose aspirin (ASA) use is associated with a lower risk for myocardial infarction (MI) and stroke, with greater benefit seen with high-frequency ...

The FDA has designated Conexxence and Bomyntra as interchangeable biosimilars to the reference products Prolia and Xgeva, ...

About 90% of women who reported moderate, severe, or very severe vasomotor symptoms did not seek medical care for symptoms.

Assisted reproductive technologies success was mainly attributed to donor eggs among women aged 43 years and older.

Empagliflozin therapy was associated with improved kidney outcomes regardless of diabetes, HF, cause of kidney disease, or severity of kidney disease.

Since Serena Williams’s endorsement of GLP-1 medications, questions have risen regarding stigma and their performance-enhancing potential.